The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca Spain; Bayer; Bristol-Myers Squibb; Clovis Oncology; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar; PharmaMar; Roche; SERVIER
Analysis of response rate with anti-PD1/PDL1 antibodies in advanced solid tumors: A meta-analysis of randomized clinical trials (RCT).
 
Alberto Carretero-González
No Relationships to Disclose
 
David Lora
No Relationships to Disclose
 
Ismael Ghanem
No Relationships to Disclose
 
Jon Zugazagoitia
No Relationships to Disclose
 
Daniel Castellano
No Relationships to Disclose
 
Juan Manuel Sepúlveda
No Relationships to Disclose
 
Jose A. Lopez-Martin
Stock and Other Ownership Interests - PharmaMar
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PharmaMar
Travel, Accommodations, Expenses - MSD Oncology; Novartis; PharmaMar
 
Guillermo de Velasco
Employment - GlaxoSmithKline (I)
Consulting or Advisory Role - Astellas Medivation; Bayer; Janssen; Novartis; Pfizer
 
Luis G. Paz-Ares
No Relationships to Disclose